Cancer Treatment Reviews
Volume 36, Issue 2 , Pages 142-150 , April 2010

Exploiting cellular pathways to develop new treatment strategies for AML

  • Amir T. Fathi

      Affiliations

    • Division of Hematologic Malignancies, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, 1650 Orleans Street, Baltimore, MD 21231, United States
  • ,
  • Steven Grant

      Affiliations

    • Department of Biochemistry and Molecular Biology, Virginia Commonwealth University School of Medicine and Massey Cancer Center, MCV Station Box 230, Richmond, VA 23298, United States
    • Fax: +1 804 225 3788.
  • ,
  • Judith E. Karp

      Affiliations

    • Division of Hematologic Malignancies, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, 1650 Orleans Street, Baltimore, MD 21231, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 410 503 5399; fax: +1 410 614 1005.

Received 11 September 2009 ,Revised 1 December 2009 ,Accepted 5 December 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0305-7372(09)00186-8

doi: 10.1016/j.ctrv.2009.12.004

Cancer Treatment Reviews
Volume 36, Issue 2 , Pages 142-150 , April 2010